Dr Reddy’s Strikes $67m Deal With Alvotech On Denosumab

Indian Firm Gains Rights In US And Europe; Builds Infrastructure For Biosimilars Unit

 
• By David Wallace
Handshake
Alvotech and Dr Reddy’s are collaborating on denosumab in the US and Europe

More from Deals

More from Business